Tali Digital (AU:TD1)
ASX:TD1
Top Page
Tali Digital
(Sydney:TD1)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.04
▼(-35.00% Downside)
Action:UpgradedDate:12/30/25
The score is primarily constrained by weak financial performance (sharp revenue decline, persistent losses, and ongoing negative free cash flow). Technical signals also indicate weak momentum (negative MACD, RSI below 50, and price below the 20-day average). Valuation is difficult to support given negative earnings and no stated dividend yield.
Positive Factors
Low leverage / conservative balance sheet
Zero reported debt in 2024–2025 gives the company structural financial flexibility versus leveraged peers. Low leverage reduces immediate solvency pressure, supports continued R&D and commercialization efforts, and lowers interest obligations that could otherwise exacerbate cash burn over the next 2–6 months.
Negative Factors
Severe revenue decline and volatility
A near-total collapse in reported revenue signals fundamental market or execution problems: failed commercial traction, lost customers, or discontinued revenue lines. Such volatility undermines predictability, impairs scaling, and makes it hard to justify continued investment absent clear recovery drivers.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / conservative balance sheet
Zero reported debt in 2024–2025 gives the company structural financial flexibility versus leveraged peers. Low leverage reduces immediate solvency pressure, supports continued R&D and commercialization efforts, and lowers interest obligations that could otherwise exacerbate cash burn over the next 2–6 months.
Read all positive factors
Tali Digital (TD1) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.87M
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)-0.96
Revenue GrowthN/A
EPS Growth78.95%
CountryAU
Employees5
SectorTechnology
Sector Strength88
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.01
Shares Outstanding46,727,478
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.47
Price to Sales (P/S)2806.10
P/FCF Ratio-7.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tali Digital Business Overview & Revenue Model
Company Description
TALi Digital Limited, a digital health company, delivers diagnostic and therapeutic solutions to improve cognitive function and behaviour in Australia. The company offers TALi DETECT, a 20-30 minute evidence-based digital screening program compris...
How the Company Makes Money
null...
Tali Digital Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
48
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.02K | 1.19K | 2.00K | 26.63K | 13.16K | 34.24K |
| Gross Profit | -127.29K | 1.19K | -449.55K | -1.49M | -3.59M | -2.59M |
| EBITDA | -969.79K | -711.29K | -1.05M | -2.54M | -7.17M | -4.69M |
| Net Income | -963.79K | -656.88K | -3.12M | -2.26M | -6.94M | -4.86M |
Balance Sheet | ||||||
| Total Assets | 2.77M | 2.66M | 2.19M | 8.09M | 6.44M | 9.83M |
| Cash, Cash Equivalents and Short-Term Investments | 1.26M | 1.30M | 2.13M | 2.99M | 1.85M | 2.73M |
| Total Debt | 0.00 | 0.00 | 0.00 | 505.49K | 504.12K | 55.79K |
| Total Liabilities | 487.56K | 386.89K | 41.61K | 2.92M | 3.01M | 2.58M |
| Stockholders Equity | 2.29M | 2.27M | 2.15M | 5.17M | 3.43M | 7.26M |
Cash Flow | ||||||
| Free Cash Flow | -742.53K | -472.81K | -363.35K | -2.82M | -4.34M | -7.37M |
| Operating Cash Flow | -742.54K | -472.81K | -363.35K | -2.00M | -4.33M | -5.80M |
| Investing Cash Flow | -1.18M | -1.10M | 0.00 | -817.64K | -12.63K | -1.57M |
| Financing Cash Flow | 1.25M | 747.00K | -503.74K | 3.96M | 3.46M | 6.17M |
Tali Digital Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$141.94M | -13.72 | -226.75% | ― | 21.56% | -24.08% | |
44 Neutral | AU$40.69M | -5.70 | -14.19% | ― | 3.61% | -17.03% | |
43 Neutral | AU$1.87M | -1.11 | -42.29% | ― | ― | 78.95% | |
42 Neutral | AU$12.74M | -0.80 | -137.16% | ― | -48.41% | -7200.00% | |
42 Neutral | AU$12.44M | -2.48 | -578.72% | ― | 241.34% | 44.19% | |
42 Neutral | AU$40.76M | -3.13 | -1009.84% | ― | 25.98% | 22.10% |
* Technology Sector Average
AU:TD1
Tali Digital
0.04
-0.03
-42.86%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.19
-0.11
-38.33%
AU:BMT
Beamtree Holdings Ltd
0.14
-0.10
-41.67%
AU:AHE
MedAdvisor Limited
0.02
-0.09
-81.82%
AU:ICR
InteliCare Holdings Limited
0.02
0.01
100.00%
AU:PCK
PainChek Ltd
0.20
-0.15
-44.29%
Tali Digital Corporate Events
Tali Digital Files Final Director Interest Notice for Departing Board Member
Mar 24, 2026
Tali Digital Limited has announced that director Mark Simari ceased to be a director effective 24 March 2026, with this filing serving as his final director’s interest notice to the ASX. The notice confirms that Simari holds no securities in...
TALi Digital Refreshes Board as It Deepens Push into Digital Cognitive Health and Education
Mar 23, 2026
TALi Digital has appointed investment and corporate strategy specialist Will Hamilton as a Non-Executive Director, bringing experience across technology investing, digital assets, MA and corporate restructuring from roles at DigitalX, Animoca Bran...
TALi Digital Completes YCDI! Digital Overhaul and Targets Growth in 2026
Jan 29, 2026
TALi Digital has completed the integration and digital transformation of its YCDI! Education business, migrating its course portfolio to the CANVAS learning management system and launching a modernised website with flexible subscription options to...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.